Skip to content
Sign in
CVE-2024-34299.8CriticalCWE-29

CVE-2024-3429: Path Traversal in parisneo/lollms

parisneo · parisneo/lollms

Vendor fix available · Affected: parisneo/lollms · Exploitation: likely to be exploited (10% or more)

Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.

28.3%probability of exploitation in the next 30 days
98th percentile
050100

Higher than 98% of scored CVEs

9.8CriticalCVSS 3.0
LowCrit.

DescriptionCVE.org

A path traversal vulnerability exists in the parisneo/lollms application, specifically within the `sanitize_path_from_endpoint` and `sanitize_path` functions in `lollms_core\lollms\security.py`. This vulnerability allows for arbitrary file reading when the application is running on Windows. The issue arises due to insufficient sanitization of user-supplied input, enabling attackers to bypass the path traversal protection mechanisms by crafting malicious input. Successful exploitation could lead to unauthorized access to sensitive files, information disclosure, and potentially a denial of service (DoS) condition by including numerous large or resource-intensive files. This vulnerability affects the latest version prior to 9.6.

Affected products1

From the CVE record. A product or version that is not listed is unknown, not unaffected.

  • parisneo · parisneo/lollmsbefore 9.6

On the Atlas

Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.

Open the Atlas
Exploitation
Likely to be exploited (10% or more). EPSS gives it a 10% or higher chance of exploitation in the next 30 days.
CISA KEV
Not listed
Public check
No public nuclei template
Vendor
parisneo
Published
June 2024

CoverageNo articles yet

No CyberSIXT article names CVE-2024-3429 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.

References

Updated AboutDevelopersSign in